Compare OVID & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | EVH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 469.0M |
| IPO Year | 2017 | 2015 |
| Metric | OVID | EVH |
|---|---|---|
| Price | $2.26 | $4.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 15 |
| Target Price | $4.60 | ★ $7.93 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | N/A |
| Revenue | $7,252,000.00 | ★ $907,957,000.00 |
| Revenue This Year | N/A | $33.89 |
| Revenue Next Year | $19.34 | $15.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $0.29 | $2.10 |
| 52 Week High | $3.11 | $11.92 |
| Indicator | OVID | EVH |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 62.14 |
| Support Level | $1.95 | $3.67 |
| Resistance Level | $2.38 | $8.30 |
| Average True Range (ATR) | 0.17 | 0.33 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 14.97 | 81.78 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.